Peptide Schedule
GLOW Blend (BPC-157 + TB-500 + GHK-Cu)25 residues (approx.)GEPPPGKPADDAGLVLKKTETQGHKEach bubble = one amino acid. Size = residue mass. Color = chemical class.Uses closest standard amino acids for non-standard residues.GLOW Blend (BPC-157 + TB-500 + GHK-Cu)
Benefits
About GLOW Blend (BPC-157 + TB-500 + GHK-Cu)
The GLOW Blend is a three-peptide healing protocol that combines BPC-157, TB-500, and GHK-Cu into a single daily injection. It builds on the Wolverine Stack (BPC-157 + TB-500) by adding GHK-Cu for collagen synthesis and anti-aging benefits. BPC-157 drives targeted tissue repair through angiogenesis and growth factor upregulation at the injury site. TB-500 acts systemically, reducing inflammation body-wide and promoting cell migration to damaged areas via actin upregulation. GHK-Cu — a copper-binding tripeptide — adds a third dimension by stimulating collagen synthesis, remodeling scar tissue, and activating genes associated with tissue regeneration. GLOW is focused on regenerative, aesthetic, and anti-aging wellness.
Who Should Consider GLOW Blend (BPC-157 + TB-500 + GHK-Cu)
- Athletes recovering from injuries
- Post-surgical recovery patients
- Individuals with chronic tendon or ligament issues
- Those seeking accelerated wound healing
- People with joint pain or chronic inflammation
How GLOW Blend (BPC-157 + TB-500 + GHK-Cu) Works
The Wolverine Stack works through three distinct but complementary repair pathways. BPC-157 upregulates VEGF to stimulate angiogenesis and new blood vessel formation at injury sites, modulates nitric oxide for vascular protection, and activates the FAK-paxillin pathway for tendon and ligament repair. TB-500 (the active fragment of Thymosin Beta-4) upregulates actin, a cell-building protein that enables cell migration and proliferation at wound sites, while reducing pro-inflammatory cytokines throughout the body. GHK-Cu binds copper ions and delivers them to tissue, activating collagen I and III synthesis, promoting decorin expression for organized tissue remodeling, and upregulating multiple genes involved in wound contraction and scar reduction. Together, the three peptides cover local repair (BPC-157), systemic healing and anti-inflammation (TB-500), and structural remodeling and anti-aging (GHK-Cu).
What to Expect
Reduced inflammation and pain at injury sites. Initial healing response begins.
Noticeable improvement in mobility and tissue repair. Collagen remodeling from GHK-Cu becomes apparent.
Significant recovery milestones. Scar tissue softening. Many users report near-full recovery from moderate injuries. End of standard 6-week cycle — evaluate results.
Two-week break. Healing continues from accumulated effects. Assess whether another cycle is needed or transition to single-peptide maintenance.
Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 750mcg | Daily |
| Moderate | 1,450mcg | Daily |
| Aggressive | 2,250mcg | Daily |
Note: Three-peptide healing blend: BPC-157 (500mcg) + TB-500 (750mcg) + GHK-Cu (200mcg). Dose shown is the combined total per injection. GLOW builds on the Wolverine Stack by adding GHK-Cu for collagen and anti-aging benefits. Pre-mixed vials simplify dosing into a single daily injection.
How to Inject GLOW Blend (BPC-157 + TB-500 + GHK-Cu)
Inject subcutaneously once daily, ideally near the injury site when targeting a specific area. For general healing and systemic recovery, abdominal subcutaneous injection is standard. Use a single injection from the pre-mixed vial. Rotate injection sites to prevent tissue irritation. Best administered in the morning or post-workout. Store reconstituted vial in the refrigerator between uses.
Cycling Protocol
Run for 4-8 weeks depending on injury severity. Take 2 weeks off before repeating. For acute injuries, 4-6 weeks is typical. For chronic conditions, some users extend to 8 weeks with provider oversight.
Pharmacokinetics
Source: Estimated from primary component BPC-157 (~4h). TB-500 half-life is 7-10 days systemically. GHK-Cu half-life is ~1 hour. Effective duration is driven by the longest-acting component.
Loading the interactive decay curve.
Side Effects
Generally well-tolerated. Mild headache, nausea, or lightheadedness reported occasionally. Injection site reactions including redness or irritation. GHK-Cu may cause mild skin flushing due to copper content. Individual component side effects may apply.
Contraindications
- Active cancer or history of cancer (BPC-157 promotes angiogenesis which may feed tumor growth)
- Pregnancy or breastfeeding
- Wilson's disease or copper metabolism disorders (due to GHK-Cu)
- Active bleeding disorders
- Known allergy to any component peptide
Drug Interactions
- Anticoagulants (TB-500 may affect clotting pathways)
- Copper supplements (risk of copper overload with GHK-Cu)
- Immunosuppressants (may alter immune modulation effects)
- NSAIDs (BPC-157 may counteract NSAID-induced GI damage, but interactions are unstudied in humans)
Storage & Stability
Molecular Profile
Related Peptides
References
- Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tractPubMed 21030672
- Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblastsPubMed 24186735
- Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repairPubMed 15226823
- Thymosin beta 4 promotes dermal healingPubMed 17507837
- GHK peptide as a natural modulator of multiple cellular pathways in skin regenerationPubMed 25789553
- GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genesPubMed 22585525
- BPC 157 and blood vesselsPubMed 29998800